Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Face Your Hands: National Survey from Nestlé Skin Health Reveals How U.S. Women Feel about Their Aging Hands

Nestlé Skin Health
Posted on: 25 Jul 18
Face Your Hands: National Survey from Nestlé Skin Health Reveals How U.S. Women Feel about Their Aging Hands Nearly 80% of Women Age 40 and Over Wish They Could Change the Way Their Hands Look1*

PR Newswire

FORT WORTH, Texas, July 25, 2018

FORT WORTH, Texas, July 25, 2018 /PRNewswire/ -- Nestlé Skin Health, who recently received FDA approval of its dermal filler Restylane®Lyft to restore age-related volume to the back of the hands, announced today results of the 'Face Your Hands' survey showing the majority (78 percent) of women ages 40 and older wish they could change the way their hands look.1* Additionally, 60 percent reported they have actually taken steps to hide their hands because they are self-conscious about the way their hands look, and nearly 2 in 3 (63 percent) women are interested in having a non-surgical cosmetic procedure or treatment to improve the appearance of their hands.1*

*The nationally representative survey was conducted by Wakefield Research among 1,000 U.S. women, ages 35+ between February 26 and March 5, 2018 using an e-mail invitation and an online survey. The data points in this release represent data collected among women ages 40+.

"Over time, the skin on the hands loses volume, which can result in a less youthful appearance,"2 stated Dr. Joel L. Cohen of Colorado, Board-Certified dermatologist and clinical trial investigator for Restylane Lyft for the hands. "I find that while many women spend time perfecting their facial beauty routine, they tend to forget about their hands. I am excited that there is now a hyaluronic acid-based treatment available to treat and help restore volume to the back of the hands, which is a problem area for many of my patients."2

While the survey found that women want to change the appearance of their hands, most (54 percent) believed there was nothing that could be done to prevent signs of aging on their hands.1* Among the other survey findings:

  • The majority (85 percent) have noticed signs of aging on their hands as they've grown older.1*
  • Nearly 2 in 3 (65 percent) women think their hands make them look older than their age.1*
  • Nearly 3 in 5 (56 percent) women have mistakenly thought someone was older than they were because of the way their hands looked.1*
  • Half (50 percent) of women polled are likely to use a filter or photo editor to improve the look of their hands before posting a picture of their hands on social media.1*

"This survey reflects what I hear from many of my patients who feel that their aging hands do not match their youthful faces," said dermatologist Dr. Ava Shamban. "Most women don't realize that the appearance of prominent wrinkles, bones, bulging veins and visible tendons are signs of volume loss in the hands and contribute to an aged look. The recent FDA approval of Restylane Lyft for the hands expands its use beyond the face to help provide an overall youthful look for my patients."

Restylane Lyft is the first and only hyaluronic acid (HA) dermal filler FDA-approved for both helping to reverse the signs of volume loss in aging hands, as well smoothing facial wrinkles and folds.3,4 It is the first and only dermal filler with 3 FDA-approved treatment areas - the midface/cheek area, nasolabial folds, and now the back of the hands.3,4 It is also the first and only HA dermal filler to receive FDA approval for an area other than the face.3,4

"This new indication for Restylane Lyft is the latest example of how Nestlé Skin Health is pushing the boundaries of innovative aesthetic solutions," said Alisa Lask, General Manager & Vice President, U.S. Aesthetic Business Unit of Nestlé Skin Health. "Women are seeking treatments to reverse the signs of aging on their hands. We're extremely pleased to be able to offer a safe and effective treatment that can help complete an overall youthful appearance."

With over 30 million treatments worldwide and counting5, the Restylane® family of HA dermal fillers is the broadest portfolio of dermal fillers in the U.S. The portfolio of products help to smooth facial wrinkles and folds, such as smile lines (Restylane®-L, Restylane®Refyne, Restylane®Defyne and Restylane®Lyft with Lidocaine), create fuller and more accentuated lips (Restylane®Silk and Restylane®-L), and add lift and volume to the cheeks and the back of the hands (RestylaneLyft with Lidocaine).

To learn more about the Restylane family of products, visit www.RestylaneUSA.com.

Nestlé Skin Health's mission is to enhance quality of life by delivering science-based solutions for the health of skin, hair and nails. As one of the category's leading companies, Nestlé Skin Health conducts ground-breaking product research to provide both the healthcare community and the consumer with an ongoing progression of innovative technologies and products to protect, serve and enhance skin health. For more information, please visit www.nestleskinhealth.com.

To earn exclusive rewards, bonuses and discounts on Nestlé Skin Health's aesthetic treatments, join the ASPIRE Rewards program. To learn more about ASPIRE, visit www.aspirerewards.com.

Important Safety Information
The Restylane family of products includes Restylane®, Restylane-L®, Restylane® Lyft with Lidocaine, Restylane® Silk, Restylane® Refyne, and Restylane® Defyne.

APPROVED USES
Restylane®and Restylane-are for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Restylane®and Restylane-L®are also indicated for injection into the lips in patients over the age of 21.

Restylane® Lyft with Lidocaine is for deep implantation into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and for cheek augmentation and for the correction of age-related midface contour deficiencies in patients over the age of 21. Restylane®Lyft with Lidocaine is also indicated for injection into the subcutaneous plane in the dorsal hand to correct volume deficit in patients over the age of 21.

Restylane® Silk is for lip augmentation and for correction of perioral wrinkles in patients over the age of 21.

Restylane® Refyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in patients over the age of 21.

Restylane® Defyne is for mid-to-deep injection into the facial tissue for the correction of moderate to severe deep facial wrinkles and folds, such as nasolabial folds, in patients over the age of 21.

Are there any reasons why I should not use products within the Restylane®family? (Contraindications)

To ensure a safe procedure, your doctor will talk to you about your medical history to determine if you are an appropriate candidate for treatment. You should not use products within the Restylane family if:

  • You have severe allergies with a history of severe reactions (anaphylaxis)
  • You are allergic to lidocaine or to any of the gram-positive bacterial proteins used to make hyaluronic acid
  • You are prone to bleeding or have been diagnosed with a bleeding disorder

Are there other precautions that I should discuss with my doctor?

  • Tell your doctor if you are breastfeeding, pregnant, or trying to become pregnant. The safety of these products for use during pregnancy, or in women who are breastfeeding, has not been studied
  • Restylane, Restylane-L, Restylane® Lyft with Lidocaine, Restylane Refyne and Restylane Defyne are intended to treat facial wrinkles and folds, such as nasolabial folds. Restylane and Restylane-L are also intended for lip enhancement. Restylane® Lyft with Lidocaine is also intended for injection in the dorsal hand to correct volume loss. Treatments in other areas of the face or body have not been evaluated in clinical studies.
  • The safety and effectiveness of Restylane® Silk for areas other than the lips and perioral area have not been evaluated in clinical studies.
  • Tell your doctor if you have any history of scarring, particularly thick and stiff scars, or any pigmentation (skin color) disorders. These side effects can occur with hyaluronic acid fillers in general.
  • Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible risk of inflammation at the treatment site if these procedures are performed after treatment
  • Patients who experience skin injury near the site of injection with these products may be at a higher risk for side effects
  • Tell your doctor if you are on any medications to decrease your body's immune response (immunosuppressive therapy). Using these medications may increase your risk of bruising or bleeding at the gel injection site.
  • Tell your doctor if you are using any "blood thinners" such as aspirin, warfarin, or any other medications that affect bleeding. Using these medications may increase your risk of bruising or bleeding at the gel injection site.
  • The use of these products on gel injection sites with skin sores, pimples, rashes, hives, cysts, or infections should be postponed until healing is complete. Use of product in these areas could delay healing or make your skin problems worse.
  • Tell your doctor if you have diseases, injuries, or disabilities of the hand.

What are the possible side effects?
The most commonly observed side effects are swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function. These are typically mild in severity and typically resolve in less than 7 days in nasolabial folds and less than 14 days in lips. Serious but rare side effects include delayed onset infections, recurrence of herpetic eruptions, and superficial necrosis at the injection site.

One of the risks with using this product is unintentional injection into a blood vessel. The chances of this happening are very small, but if it does happen, the complications can be serious, and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin.

As with all skin injection procedures, there is a risk of infection.

To report a side effect with any of the Restylane products, please call Galderma Laboratories, L.P at 1-855-425-8722.

The Restylane family of products is available only through a licensed practitioner. Complete Instructions for Use are available at www.RestylaneUSA.com.

1 Data on file. Restylane Survey Demographic Report (Wakefield Research), March 2018.
2 Fabi SG, Goldman MP. Hand rejuvenation: a review and our experience. Dermatol Surg. 2012 Jul;38(7 Pt 2):1112-27. doi: 10.1111/j.1524-4725.2011.02291.x.
3Restylane Lyft. Instructions for Use. Fort Worth, TX. Galderma Laboratories, L.P., 2018
4 U.S. Food & Drug Administration. Dermal Fillers Approved by the Center for Devices and Radiological Health. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/CosmeticDevices/WrinkleFillers/ucm227749.htm. Accessed May 15, 2018.
5 Data on file. MA-31037 document. Fort Worth, TX: Galderma Laboratories, L.P., 2016.

© 2018 Galderma Laboratories, L.P.
All trademarks are the property of their respective owners.

View original content with multimedia:http://www.prnewswire.com/news-releases/face-your-hands-national-survey-from-nestle-skin-health-reveals-how-us-women-feel-about-their-aging-hands-300686196.html

SOURCE Nestlé Skin Health

PR Newswire
www.prnewswire.com

Last updated on: 25/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.